Synonyms: compound 41 [PMID: 34550687] | FRM024
Compound class:
Synthetic organic
Comment: FRM-024 is a CNS-penetrating γ secretase modulator that was developed for its capacity to improve amyloid processing and potential as an Alzheimer's disease therapeutic [1]. Gamma secretase modulators reduce the levels of the toxic longer amyloid β (Aβ) chains (Aβ42, Aβ43) that accummulate in Alzheimer's brains. They do not alter total Aβ levels. In particular, such modulators may afford potential for clinical intervention in patients with inherited loss-of-function mutations in presenilin genes which increase production of the toxic forms of Aβ.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(5S,6R)-5-(4-chlorophenyl)-6-cyclopropyl-3-[6-methoxy-5-(4-methylimidazol-1-yl)pyridin-2-yl]-5,6-dihydro-2H-1,2,4-oxadiazine |
Synonyms ![]() |
compound 41 [PMID: 34550687] | FRM024 |
Database Links ![]() |
|
GtoPdb PubChem SID | 458923787 |
PubChem CID | 126599754 |
Search Google for chemical match using the InChIKey | IOQORVDNYPOZPL-VQTJNVASSA-N |
Search Google for chemicals with the same backbone | IOQORVDNYPOZPL |
UniChem Compound Search for chemical match using the InChIKey | IOQORVDNYPOZPL-VQTJNVASSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | IOQORVDNYPOZPL-VQTJNVASSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
(-)-FRM-024 (links to external site)
Cat. No. HY-115726A |